US Pharma MarketingFDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy
FDA grants accelerated approval to Ultragenyx’s Genglycos gene therapy is a pharma and life sciences industry update from Pharmaceutical Technology. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.
Ultragenyx Pharmaceutical has received accelerated approval from the FDA for its gene therapy, Genglycos, to treat GSDIa.
Source: Pharmaceutical Technology